君实生物:公司一直高度重视市值管理工作,并且已从多方面积极推进相关举措

互动易
18 Feb

有投资者向君实生物提问, 董秘,公司自从上市以来 股价持续下跌,亏损幅度远超过50%,公司作为科创板成份股之一,公司有市值管理的相关措施吗?公司有给投资者回报的计划吗?公司回答表示,投资人您好,公司一直高度重视市值管理工作,并且已从多方面积极推进相关举措。在经营层面,公司推动提质降本增效工作,持续提高商业化效率,不断优化产品组合,致力于推动业务稳健增长,以夯实公司业绩基础,为市值提升提供有力支撑。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10